Gain Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GANX and other ETFs, options, and stocks.

About GANX

Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never targeted before. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. 

CEO
Gene C. Mack
CEOGene C. Mack
Employees
25
Employees25
Headquarters
Bethesda, Maryland
HeadquartersBethesda, Maryland
Founded
2017
Founded2017
Employees
25
Employees25

GANX Key Statistics

Market cap
68.27M
Market cap68.27M
Price-Earnings ratio
-2.74
Price-Earnings ratio-2.74
Dividend yield
Dividend yield
Average volume
583.28K
Average volume583.28K
High today
$1.85
High today$1.85
Low today
$1.60
Low today$1.60
Open price
$1.63
Open price$1.63
Volume
692.11K
Volume692.11K
52 Week high
$4.34
52 Week high$4.34
52 Week low
$1.41
52 Week low$1.41

Stock Snapshot

With a market cap of 68.27M, Gain Therapeutics(GANX) trades at $1.82. The stock has a price-to-earnings ratio of -2.74.

On 2026-02-07, Gain Therapeutics(GANX) stock traded between a low of $1.60 and a high of $1.85. Shares are currently priced at $1.82, which is +13.7% above the low and -1.6% below the high.

Gain Therapeutics(GANX) shares are trading with a volume of 692.11K, against a daily average of 583.28K.

In the last year, Gain Therapeutics(GANX) shares hit a 52-week high of $4.34 and a 52-week low of $1.41.

In the last year, Gain Therapeutics(GANX) shares hit a 52-week high of $4.34 and a 52-week low of $1.41.

People also own

Based on the portfolios of people who own GANX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.